My work focuses on the development and evaluation of vaccines for emerging infectious diseases such as dengue and Zika. I have collaborated with vaccine manufacturers in India to manufacture and evaluate a live attenuated tetravalent dengue vaccine in India. The U.S. National Institutes of Health as licensed this technology to several vaccine manufacturers in India with the goal of in-country production and delivery of this vaccine to benefit those at risk in India.